Orchestra BioMed Holdings, Inc.
OBIO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001814114
In the last 90 days, Orchestra BioMed Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Orchestra BioMed Holdings, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q3 2022
- Shares held
- 5.65M
- −42.4K (−0.7%) vs. Q3 2022
- Total value
- $56.6M
- +$227.9K (+0.4%) vs. Q3 2022
- New holders
- 3
- 1 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $119.4M |
| Q1 2026 | 65 | $98.2M |
| Q4 2025 | 63 | $90.1M |
| Q3 2025 | 52 | $56.1M |
| Q2 2025 | 59 | $47.6M |
| Q1 2025 | 56 | $81.3M |
| Q4 2024 | 54 | $77.0M |
| Q3 2024 | 48 | $97.8M |
| Q2 2024 | 47 | $115.9M |
| Q1 2024 | 43 | $70.3M |
| Q4 2023 | 39 | $121.2M |
| Q3 2023 | 42 | $114.2M |
| Q2 2023 | 39 | $75.5M |
| Q1 2023 | 22 | $193.2M |
| Q4 2022 | 24 | $56.6M |
| Q3 2022 | 23 | $56.4M |
| Q2 2022 | 62 | $142.3M |
| Q1 2022 | 59 | $139.4M |
| Q4 2021 | 53 | $129.0M |
| Q3 2021 | 48 | $120.6M |
| Q2 2021 | 51 | $124.1M |
| Q1 2021 | 46 | $130.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Orchestra BioMed Holdings, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Elequin Capital LP | 1,542 | $15.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,123 | $21.0K | 0.00% | 00.0% | Unchanged |
| Altium Capital Management LP | 10,000 | $99.8K | 0.05% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,421 | $124.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 15,041 | $150.1K | 0.00% | 00.0% | Unchanged |
| Berkley W R Corp | 19,902 | $198.6K | 0.01% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 26,757 | $267.0K | 0.10% | +26,757 | New |
| Rpo LLC | 27,755 | $277.0K | 0.11% | +3,554+14.7% | Added |
| TD Asset Management Inc | 46,339 | $462.9K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 49,858 | $498.0K | 0.01% | 00.0% | Unchanged |
| Graham Capital Wealth Management, LLC | 65,005 | $648.8K | 1.16% | +65,005 | New |
| PenderFund Capital Management Ltd. | 55,300 | $748.0K | 0.22% | +55,300 | New |
| Woodline Partners LP | 126,061 | $1.26M | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 170,458 | $1.70M | 0.00% | −1,350−0.8% | Reduced |
| Davidson Kempner Capital Management LP | 245,213 | $2.45M | 0.05% | 00.0% | Unchanged |
| Boxer Capital, LLC | 250,000 | $2.50M | 0.13% | −150,000−37.5% | Reduced |
| Sio Capital Management, LLC | 250,000 | $2.50M | 1.33% | 00.0% | Unchanged |
| Tang Capital Management LLC | 392,500 | $3.92M | 0.57% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 400,000 | $3.99M | 0.12% | 00.0% | Unchanged |
| Avidity Partners Management LP | 400,000 | $3.99M | 0.09% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 610,283 | $6.09M | 0.12% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 685,801 | $6.85M | 0.00% | −38,764−5.3% | Reduced |
| BlackRock Inc. | 790,436 | $7.89M | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 1,000,000 | $9.98M | 0.20% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −2,824−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −100−100.0% | Sold out |